KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Taxes (2016 - 2018)

Idexx Laboratories has reported Current Taxes over the past 9 years, most recently at $26.5 million for Q1 2018.

  • For Q1 2018, Current Taxes rose 24.35% year-over-year to $26.5 million; the TTM value through Mar 2018 reached $26.5 million, up 24.35%, while the annual FY2017 figure was $29.4 million, 22.59% up from the prior year.
  • Current Taxes for Q1 2018 was $26.5 million at Idexx Laboratories, down from $29.4 million in the prior quarter.
  • Over five years, Current Taxes peaked at $29.4 million in Q1 2015 and troughed at $15.4 million in Q1 2014.
  • A 5-year average of $23.2 million and a median of $24.0 million in 2016 define the central range for Current Taxes.
  • On a YoY basis, Current Taxes climbed as much as 91.24% in 2015 and fell as far as 33.32% in 2015.
  • Year by year, Current Taxes stood at $28.4 million in 2014, then plummeted by 33.32% to $19.0 million in 2015, then increased by 26.42% to $24.0 million in 2016, then rose by 22.59% to $29.4 million in 2017, then decreased by 9.99% to $26.5 million in 2018.
  • Business Quant data shows Current Taxes for IDXX at $26.5 million in Q1 2018, $29.4 million in Q4 2017, and $24.9 million in Q3 2017.